ISRG — Intuitive Surgical, Inc. stock price, charts and financials

QT27Intuitive Surgical, Inc.

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
389.18
+10.37+2.74%
OverviewShort InterestFilings
ISRGQT27Intuitive Surgical, Inc.·NASDAQ
389.18+2.74%
News
Up 2.7% — ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now? (zacks.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
BDX+0.59%$177.91MDLN-4.43%$33.67WST+0.42%$355.55COO+1.81%$75.57SOLV+1.87%$84.53BAX+0.67%$27.73RGEN-0.24%$163.50AVTR+0.66%$13.68
Snapshot
IndexS&P 500, NDXP/E42.80EPS (ttm)8.85Insider Own0.47%Shs Outstand353.28MPerf Week7.21%
Market Cap133.83BForward P/E31.36EPS next Y12.08Insider Trans-1.26%Shs Float351.21MPerf Month-7.96%
Enterprise Value131.06BPEG2.02EPS next Q2.61Inst Own86.89%Short Float1.91%Perf Quarter-16.47%
Income3.13BP/S12.13EPS this Y22.85%Inst Trans-Short Ratio2.64Perf Half Y-20.47%
Sales11.03BP/B7.39EPS next Y11.88%ROA15.04%Short Interest6.71MPerf YTD-33.11%
Book/sh-P/C36.23EPS next 5Y12.01%ROE17.84%52W High620.40 -37.27%Perf Year-20.09%
Cash/sh-P/FCF41.53EPS past 3/5Y29.19% 21.77%ROIC15.11%52W Low337.57 15.29%Perf 3Y20.69%
Dividend Est.-EV/EBITDA29.08Sales past 3/5Y17.39% 18.22%Gross Margin66.68%Volatility2.63% 3.34%Perf 5Y14.62%
Dividend TTM-EV/Sales11.88EPS Y/Y TTM36.92%Oper. Margin31.28%ATR (14)13.56Perf 10Y394.01%
Dividend Ex-Date-Quick Ratio3.91Sales Y/Y TTM32.11%Profit Margin28.45%RSI (14)51.32Recom2.40
Dividend Gr. 3/5Y-Current Ratio4.96EPS Q/Q27.85%SMA203.98%Beta1.45Target Price491.15
Payout0.00%Debt/Eq0.00Sales Q/Q18.52%SMA50-3.65%Rel Volume0.80Prev Close378.81
Employees17,021LT Debt/Eq0.01EarningsOct 20SMA200-21.11%Avg Volume3.07MPrice389.18
IPO DateJun 16, 2000Option/ShortYes / YesEPS/Sales Surpr.11.51% 2.37%Net Debt/EBITDA-0.61Volume2,458,292Change2.74%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-30-26DowngradeHSBCBuy → Hold$391
Jul-28-26ReiteratedUBSNeutral$570 → $500
Jul-27-26ReiteratedPiper SandlerOverweight$470 → $357
Jul-17-26ReiteratedStifel NicolausBuy$670 → $550
Jul-17-26ReiteratedRobert W. Baird$525 → $500
Jul-17-26ReiteratedBTIGBuy$512 → $469
Jul-17-26ReiteratedLeerink PartnersOutperform$454
Jul-17-26ReiteratedRaymond JamesOutperform$603 → $483
Jul-17-26ReiteratedPiper SandlerOverweight$580 → $470
Jul-17-26ReiteratedMizuhoNeutral$500 → $400
Latest News
Today
Today11:45AM
ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?zacks.com
Aug-08-26
Aug-08-2612:15PM
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTechfool.com
07:05AM
The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%247wallst.com
Aug-06-26
Aug-06-2603:41PM
Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?Yahoo
Jul-31-26
Jul-31-2607:26PM
Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?Yahoo
10:01AM
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Knowzacks.com
04:03AM
BankChampaign National Association Invests $908,000 in Intuitive Surgical, Inc. $ISRGdefenseworld.net
Jul-30-26
Jul-30-2601:41PM
Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?zacks.com
Jul-29-26
Jul-29-2610:44AM
This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Runfool.com
03:47AM
Amundi Acquires 193,096 Shares of Intuitive Surgical, Inc. $ISRGdefenseworld.net
Jul-28-26
Jul-28-2611:01AM
ISRG Q2 Earnings Call Signals Durable Demand & U.S. Cautionzacks.com
09:47AM
Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685247wallst.com
07:42AM
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More247wallst.com
07:30AM
Here's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Monthsfool.com
Jul-27-26
Jul-27-2609:15AM
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Optionsglobenewswire.com
Company

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Ownership
Total institutional ownership86.89%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue11,03410,0658,352——————
Cost of Goods Sold Incl. D&A3,6773,4222,718——————
Gross Profit7,3576,6425,634——————
Selling, General and Administrative Excl. Other2,4912,3852,140——————
Research and Development1,4151,3121,145——————
Other Operating Expense
100——————
Operating Income3,4512,9462,349——————
Interest Expense
000——————
Unusual Expense
—————————
Non-Operating Income (Expense)355366325——————
Net Income Before Taxes3,8063,3112,674——————
Income Taxes647435336——————
Consolidated Net Income3,1392,8562,323——————
Net Income From Continuing Operations3,1582,8772,338——————
Net Income3,1392,8562,323——————
EPS (Recurring)8.858.006.54——————
EPS (Basic, Before Extraordinaries)8.858.006.54——————
EPS (Diluted)8.797.876.42——————
EBITDA4,5063,9893,136——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio44.2871.9681.30——————
Price To Sales Ratio12.5220.0922.19——————
Gross Margin66.6865.9967.46——————
Operating Margin31.2829.2728.13——————
Net Margin28.4528.3827.81——————
Shares Outstanding355357355——————
Market Capitalization138,159202,191185,296——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$631.97$547.20$462.44$377.67$292.90● Close Price0.00M8.19M16.37M24.56M32.74MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Brosius MarkEVP & Chief Mfg and Supply ChaJul 31 '26Sale351.00289,8281,266Jul 31
Brosius MarkEVP & Chief Mfg and Supply ChaJul 30 '26Sale346.83289,7111,294Jul 31
Brosius MarkEVP & Chief Mfg and Supply ChaJul 29 '26Sale360.212810,0861,322Jul 29
Brosius MarkEVP & Chief Mfg and Supply ChaJul 28 '26Sale365.582810,2361,350Jul 29
Brosius MarkEVP & Chief Mfg and Supply ChaJul 27 '26Sale344.00289,6321,378Jul 29
Rosa David J.Chief Executive Officer (CEO)Jul 10 '26Option Exercise0.001,9100247,803Jul 13
Brosius MarkEVP & Chief Mfg and Supply ChaJun 12 '26Sale414.132510,3531,406Jun 12
Brosius MarkEVP & Chief Mfg and Supply ChaJun 11 '26Sale412.16239,4801,431Jun 12
Brosius MarkEVP & Chief Mfg and Supply ChaJun 10 '26Sale424.14239,7551,454Jun 10
LOEB GARYEVP & Chief Legal and ComplianJun 10 '26Sale424.14400169,6565,720Jun 10
Rosa David J.Chief Executive Officer (CEO)Jun 10 '26Option Exercise0.001,3580246,567Jun 10
Brosius MarkEVP & Chief Mfg and Supply ChaJun 09 '26Sale421.13239,6861,477Jun 10
Brosius MarkEVP & Chief Mfg and Supply ChaJun 08 '26Sale420.12239,6631,500Jun 10
Jeddi ImanSVP & GM da Vinci Platforms &Jun 01 '26Sale420.555,6252,365,5946,463Jun 02
Jeddi ImanSVP & GM da Vinci Platforms &Jun 01 '26Option Exercise77.005,625433,11912,088Jun 02
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.